Skip to content
OpenCapital
Get started

AbbVie ABBV Payment for (Proceeds from) Other Investing Activity

Payment for (Proceeds from) Other Investing Activity at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$54M+80.0%
McKesson logo
McKessonMCK
$79M+276%
Eli Lilly logo
Eli LillyLLY
——
Pfizer logo
PfizerPFE
——
Amgen logo
AmgenAMGN
——
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
——

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$449.63B+36.6%
P/E123.7×+36.2×
P/S7.2×+1.5×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Reported directly by AbbVie in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's payment for (proceeds from) other investing activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's payment for (proceeds from) other investing activity?
AbbVie (ABBV) reported payment for (proceeds from) other investing activity of $43M in Q1 2026.
How has AbbVie's payment for (proceeds from) other investing activity changed year-over-year?
AbbVie's payment for (proceeds from) other investing activity increased by 213.2% year-over-year, from -$38M to $43M.
What is the long-term trend for AbbVie's payment for (proceeds from) other investing activity?
Over 3 years (2021 to 2025), AbbVie's payment for (proceeds from) other investing activity has grown at a -57.0% compound annual growth rate (CAGR), from -$366M to $29M.
What does payment for (proceeds from) other investing activity mean?
Net cash flows resulting from investing activities that do not fall under standard categories like securities or loans. This may include investments in joint ventures, real estate, or other non-financial assets. It serves as a catch-all for miscellaneous capital deployment or divestment activities.